Latest filing published 21 Sept 2023 for Paratek Pharmaceuticals, Inc..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Adam Woodrow: trading record in brief
This profile gathers the share dealings of Adam Woodrow in Paratek Pharmaceuticals, Inc., where the filings describe the role as chief executive. We count 45 filings; the first trade dates from 4 February 2016 and the latest from 21 September 2023.
On the market, this insider has only sold: 23 sales, €1.1M in total. Besides market trades, the filings include 20 share grants.
Most recently, on 21 September 2023, the filings show a transaction in Paratek Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Adam Woodrow
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 622,284 sharesCommon StockSEC:0000899243-23-019354:0
- 98,750 shares0Common StockSEC:0000904454-23-000480:0
- 22,500 shares0Common StockSEC:0000904454-22-000655:0
- 3,820 shares@ US$1.989.8% of flowCommon StockSEC:0000904454-22-000629:0
- 4,563 shares@ US$3.4721.7% of flowCommon StockSEC:0000904454-22-000534:0
- 15,000 shares0Common StockSEC:0000904454-22-000512:0
- 71,591 shares0Common StockSEC:0000904454-22-000431:0
- 101,250 shares0Common StockSEC:0000904454-22-000270:0
- 6,422 shares@ US$4.4252.1% of flowCommon StockSEC:0000904454-21-000838:0
- 37,500 shares0Common StockSEC:0000904454-21-000622:0
- 42,955 shares0Common StockSEC:0000904454-21-000520:0
- 25,000 sharesCommon StockSEC:0000904454-16-000918:0
12 of 12 declarations
